Multiomic Integration Engine
Combines ATAC-seq, methylation, and genomic data to deliver a comprehensive view of chromatin accessibility and regulatory landscapes.
About Our Platform
A Unified Lens into the Regulatory Landscape
ChromaAccess.Ai™ is an AI-powered multiomic integration platform designed to decode chromatin accessibility with high resolution. It combines raw genomic sequences with epigenomic signatures like chromatin openness (ATAC-seq) and DNA methylation to infer functional regulatory regions across the genome. This integrated view provides deeper insight into how non-coding regions influence gene expression, helping to connect genetic variants to disease mechanisms and therapeutic opportunities.
Why Choose ChromaAccess.Ai™
From Chromatin Structure to Clinical Insight
ChromaAccess.Ai™ transforms fragmented epigenomic signals into actionable insight by integrating genomic, ATAC-seq, and methylation data to reconstruct high-resolution regulatory landscapes. It assigns functional relevance to non-coding variants, accelerates biomarker discovery, and uncovers the epigenetic mechanisms underlying disease. By bridging experimental gaps and revealing how chromatin accessibility influences gene expression and phenotype, the platform empowers researchers to make more informed, mechanistically driven decisions in diagnostics, stratification, and therapeutic development.
ChromaAccess.Ai™ is designed to seamlessly integrate into research workflows by combining genomic, ATAC-seq, and DNA methylation data. Using machine learning models trained on multiomic datasets, the platform predicts chromatin accessibility with high precision, enabling accurate mapping of active regulatory regions. This integrated approach bridges the gaps left by isolated experimental methods and generates functional insights into gene regulation, disease mechanisms, and epigenetic variation.
Key Features & Capabilities
Functional Annotation of Non-Coding Variants
Assigns biological meaning to regulatory mutations, enabling better understanding of their role in disease.
Biomarker and Target Discovery Support
Identifies regulatory elements and accessibility signatures correlated with disease, supporting novel biomarker and therapeutic target identification.
High-Resolution Accessibility Prediction
Predicts chromatin accessibility across the genome with precision, even in regions lacking direct experimental data.
Mechanistic Insight into Gene Regulation
Reveals how chromatin states influence transcriptional activity, aiding in hypothesis generation and validation.
Scalable and Interpretable Outputs
Delivers intuitive, scalable insights suited for both research and clinical applications, with outputs designed for downstream integration and reporting.
Build the future of
biology with us
Contact Us
Stay Ahead with
ThinkBio.Ai®
Subscribe to our newsletter to receive the latest updates on products, sustainability efforts and services.